獨協医科大学 · 医学部 · 肝•胆•膵外科 学内助教

研究关键词大腸癌・肝臓・胆道癌・膵臓

以下为公开数据预览。个性化匹配理由、联系角度和保存能力需要登录后使用。

• Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma., Suzuki Takashi;Mori Shozo;Shimizu Takayuki;Tago Kazuma;Harada Nobuhiro;Park Kyung-Hwa;Sakuraoka Yuhki;Shiraki Takayuki;Iso Yukihiro;Aoki Taku;Kubota Keiichi, In vivo (Athens, Greece), 33（6）, 2027-2035, 2019年11月2027 · 論文
• Impact of anastomotic leakage on postoperative survival of patients with colorectal cancer: A meta-analysis using propensity score matching studies., Ishizuka Mitsuru;Shibuya Norisuke;Takagi Kazutoshi;Hachiya Hiroyuki;Tago Kazuma;Sato Shun;Shimizu Takayuki;Matsumoto Takatsugu;Aoki Taku;Kubota Keiichi, Surgical oncology, 37, 101538, 2021年06月2021 · 論文
• Omentectomy Does Not Affect the Postoperative Outcome of Patients With Locally Advanced Gastric Cancer: A Systematic Review and Meta-Analysis., Ishizuka Mitsuru;Shibuya Norisuke;Takagi Kazutoshi;Hachiya Hiroyuki;Tago Kazuma;Matsumoto Takatsugu;Shimizu Takayuki;Aoki Taku;Kubota Keiichi, The Journal of surgical research, 264, 287-295, 2021年08月2021 · 論文
• Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma., Mori Shozo;Aoki Taku;Sakuraoka Yuhki;Shimizu Takayuki;Yamaguchi Takamune;Park Kyung-Hwa;Matsumoto Takatsugu;Shiraki Takayuki;Iso Yukihiro;Kubota Keiichi, Cancer chemotherapy and pharmacology, 88（1）, 109-120, 2021年07月2021 · 論文

• 非培養自己ヒト皮下脂肪組織由来再生幹細胞を用いた便失禁治療の開発
• 大腸癌における癌関連線維芽細胞に基づく抗がん剤治療効果予測システムの開発

• 官方个人主页